Your new post is loading...
Elevated levels of Cyclin D1b could function as a novel biomarker of lethal metastatic disease in prostate cancer patients, according to a pre-clinical study published ahead of print on December 21...Read the whole entry... »...
Via Brian Shields
|
Rescooped by Ray and Terry's from Biomarkers and Personalized Medicine |
Scoop.it!
Via Brian Shields
No comment yet.
Sign up to comment
